Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Jul-24 8:00 AM View:  | Fulcrum Therapeutics, Inc. (FULC) | 03-Jul-24 | Option Exercise | 150,000 | $3.27 | $490,500.00 | 346% 43.36K to 193.36K | |
| 05-Mar-24 4:15 PM View: | Fulcrum Therapeutics, Inc. (FULC) | 04-Mar-24 | Private Purchase | 43,360 | $11.35 | $492,028.00 | 100% 0 to 43.36K | |
| 19-May-23 4:17 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-May-23 | Option Exercise | 3,750 | -- | -- | 100% 0 to 3.75K | |
| 15-Aug-18 4:27 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 14-Aug-18 | Market Purchase | 21,700 | $22.83 | $495,411.00 | 46% 46.91K to 68.61K | (65%) |
| 27-Dec-17 4:32 PM View: | Dova Pharmaceuticals Inc. (DOVA) | 22-Dec-17 | Option Exercise | 26,809 | $3.73 | $99,997.60 | 133% 20.1K to 46.91K | |
| 07-Jul-17 6:44 AM View: | Dova Pharmaceuticals Inc. (DOVA) | 05-Jul-17 | Purchase | 20,100 | $17.00 | $341,700.00 | 100% 0 to 20.1K |